Lymphangioleiomyomatosis

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

10 events
Oct 2025The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA

University of Washington

TrialRECRUITING
Oct 2025Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)

Columbia University — PHASE1

TrialRECRUITING
Oct 2025Impact of Medicalized Residential Care (LAM) on the Development of Care Plans for Vulnerable Patients in Palliative Care

University Hospital, Strasbourg, France

TrialRECRUITING
Aug 2025A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation

Icahn School of Medicine at Mount Sinai — PHASE1

TrialRECRUITING
Jul 2025Switch to Dolutegravir Plus Lamivudine Dual-Therapy in Transgender Women Living With HIV on Virologically Suppressive Antiretroviral Therapy (TRANS-SWITCH)

UBATEC — PHASE4

TrialRECRUITING
Jul 2025Exploration of the Variability of Exposure to Antiretroviral Treatment in Hair With a View to Validating Its Value as a Diagnostic Tool for Partial and/or Total Non-compliance With Treatment

University Hospital, Toulouse

TrialRECRUITING
May 2025DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or Obesity

José Antonio Mata Marín — PHASE3

TrialRECRUITING
Apr 2025Doravirine/Lamivudine (DOR/3TC) as a Maintenance ART in Comparison With Dolutegravir/Lamivudine (DTG/3TC) in PLWH Successfully

Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida — PHASE2

TrialRECRUITING
Apr 2025Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex

University of Milan — NA

TrialRECRUITING
Apr 2025Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience

Instituto Mexicano del Seguro Social — PHASE4

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Lymphangioleiomyomatosis.
Check the disease page for updates →

Clinical Trial Landscape

11 active trials
1Phase 3
2Phase 1
2N/A
5Unknown
1PHASE1, PHASE2
11Total recruiting
Search clinical trials for Lymphangioleiomyomatosis

Recent News & Research

No recent news articles indexed yet for Lymphangioleiomyomatosis.
Search PubMed for Lymphangioleiomyomatosis

Browse all Lymphangioleiomyomatosis news →

Specialist Network

Top 6 by expertise

View all Lymphangioleiomyomatosis specialists →

Quick Actions